150 related articles for article (PubMed ID: 33585343)
21. Flow-driven right-to-left cardiac shunting in a patient with carcinoid heart disease and patent foramen ovale without elevated right atrial pressure: a case report and literature review.
Dherange P; Telles N; Modi K
Eur Heart J Case Rep; 2020 Dec; 4(6):1-5. PubMed ID: 33442599
[TBL] [Abstract][Full Text] [Related]
22. Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management.
Jin C; Sharma AN; Thevakumar B; Majid M; Al Chalaby S; Takahashi N; Tanious A; Arockiam AD; Beri N; Amsterdam EA
Cardiology; 2021; 146(1):65-73. PubMed ID: 33070143
[TBL] [Abstract][Full Text] [Related]
23. Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report.
Khay K; Arous S; Bentaoune T; Drighil A; Habbal R
J Med Case Rep; 2018 Jan; 12(1):23. PubMed ID: 29386066
[TBL] [Abstract][Full Text] [Related]
24. A clinical and echocardiographic case report of carcinoid-related valvular heart disease.
Ebrahimi AJ; Marogil P; Von Mering G; Ahmed M
Eur Heart J Case Rep; 2020 Dec; 4(6):1-4. PubMed ID: 33442593
[TBL] [Abstract][Full Text] [Related]
25. Telotristat ethyl: a new option for the management of carcinoid syndrome.
Lamarca A; Barriuso J; McNamara MG; Hubner RA; Valle JW
Expert Opin Pharmacother; 2016 Dec; 17(18):2487-2498. PubMed ID: 27817224
[TBL] [Abstract][Full Text] [Related]
26. Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.
Kulke MH; O'Dorisio T; Phan A; Bergsland E; Law L; Banks P; Freiman J; Frazier K; Jackson J; Yao JC; Kvols L; Lapuerta P; Zambrowicz B; Fleming D; Sands A
Endocr Relat Cancer; 2014 Oct; 21(5):705-14. PubMed ID: 25012985
[TBL] [Abstract][Full Text] [Related]
27. Results of Contemporary Valve Surgery in Patients with Carcinoid Heart Disease.
Kuntze T; Owais T; Secknus MA; Kaemmerer D; Baum R; Girdauskas E
J Heart Valve Dis; 2016 May; 25(3):356-363. PubMed ID: 27989047
[TBL] [Abstract][Full Text] [Related]
28. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
[TBL] [Abstract][Full Text] [Related]
29. [The ectopic ACTH syndrome].
Penezić Z; Savić S; Vujović S; Tatić S; Ercegovac M; Drezgićc M
Srp Arh Celok Lek; 2004; 132(1-2):28-32. PubMed ID: 15227962
[TBL] [Abstract][Full Text] [Related]
30. Atypical presentation of carcinoid tumor with unresolved right shoulder pain: a case report.
Tun NT; Oza R
J Med Case Rep; 2014 May; 8():142. PubMed ID: 24885024
[TBL] [Abstract][Full Text] [Related]
31. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.
Pavel ME; Phan AT; Wolin EM; Mirakhur B; Liyanage N; Pitman Lowenthal S; Fisher GA; Vinik AI;
Oncologist; 2019 Apr; 24(4):463-474. PubMed ID: 30355775
[TBL] [Abstract][Full Text] [Related]
32. High-dose lanreotide in the treatment of poorly differentiated pancreatic neuroendocrine carcinoma: a case report.
Van Fraeyenhove F; Meireson N; Terriere L; Willemsen P; Kunnen J; Mattelaer C; Van Acker F; Schrijvers D
Case Rep Oncol; 2014 Jan; 7(1):155-63. PubMed ID: 24707264
[TBL] [Abstract][Full Text] [Related]
33. Failing stentless Bioprostheses in patients with carcinoid heart valve disease.
Schaefer A; Sill B; Schoenebeck J; Schneeberger Y; Reichenspurner H; Gulbins H
J Cardiothorac Surg; 2015 Mar; 10():41. PubMed ID: 25880286
[TBL] [Abstract][Full Text] [Related]
34. [Carcinoid tumors: echocardiographic contribution to the diagnosis].
Amador P; Mendes L; Gonçalves S; Santos JF; Seixo F; Parreira L; Soares L
Acta Med Port; 2011; 24(5):843-8. PubMed ID: 22525639
[TBL] [Abstract][Full Text] [Related]
35. Carcinoid heart disease involving the left heart: a case report and biomarker analysis.
Lichtenauer M; Pichler T; Eder S; Mirna M; Magnes T; Wernly B; Paar V; Jung C; Prinz E; Seitelberger R; Hoppe UC
ESC Heart Fail; 2019 Feb; 6(1):222-227. PubMed ID: 30620449
[TBL] [Abstract][Full Text] [Related]
36. Carcinoid Syndrome-Induced Ventricular Tachycardia.
Rupp AB; Ahmadjee A; Morshedzadeh JH; Ranjan R
Case Rep Cardiol; 2016; 2016():9142598. PubMed ID: 27088017
[TBL] [Abstract][Full Text] [Related]
37. Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea.
Lyseng-Williamson KA
Drugs; 2018 Jun; 78(9):941-950. PubMed ID: 29931594
[TBL] [Abstract][Full Text] [Related]
38. Two-dimensional echocardiography in the diagnosis of carcinoid heart disease.
Forman MB; Byrd BF; Oates JA; Robertson RM
Am Heart J; 1984 Mar; 107(3):492-6. PubMed ID: 6695693
[TBL] [Abstract][Full Text] [Related]
39. Telotristat ethyl for the treatment of carcinoid syndrome diarrhea not controlled by somatostatin analogues.
Kasi PM
Drugs Today (Barc); 2018 Jul; 54(7):423-432. PubMed ID: 30090879
[TBL] [Abstract][Full Text] [Related]
40. Misleading clinical presentation of carcinoid syndrome.
Famerée L; Van Lier C; Borbath I; Yildiz H; Lemaire J; Baeck M
Acta Gastroenterol Belg; 2021; 84(3):501-503. PubMed ID: 34599576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
